drugset / Trial / NCT00002444

A Study of Nitazoxanide in the Treatment of AIDS-Related Diarrhea

NCT00002444

Phase 1 Completed 28 enrolled Unimed Pharmaceuticals
Treatment

Summary

To determine the pharmacokinetics profile of single doses of nitazoxanide (NTZ) in patients with AIDS-related cryptosporidial diarrhea. To determine steady state concentrations of NTZ following repeated dosing. To assess the safety and efficacy of 4 dose levels of NTZ in these patients. Cryptosporidial enterocolitis in AIDS patients is frequently chronic and severe, contributing substantially to morbidity, mortality, and health care costs in this population. NTZ exhibits antimicrobial activity that may extend to Cryptosporidial infection.

Timeline

Start
1995-10
Primary completion
Completion
1996-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitazoxanide Other / unclassified